This is a Novo Nordisk Sponsored meeting
Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.
Management of Obesity –NHS endorsed initiatives, therapies and pharmacotherapies
Tuesday 8th November 2022, 19.00 - 20.00
In the first of this webinar series focussing on obesity, join Dr Hazlehurst and an expert panel to discuss the management of obesity focusing on NHS endorsed initiatives, therapies and pharmacotherapies.
Discussions will cover;
- Understanding of current and projected obesity pharmacotherapy within the UK
- Understanding the impact of pharmacotherapy on patient outcomes and service use
- Understand the impact of pharmacotherapy on the delivery of UK obesity services and the anticipated effect in the coming years
Please join us for the live Q & A during this session.
This webinar is for UK Healthcare professionals only